The Patent Finder

Crystalline Form I of Ibrutinib

Crystal Pharmatech Co., Ltd.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 2 of these applications claim priority to application PCT/US2015/064432, filed Dec 8, 2015. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 9,751,889Crystalline Form I of Ibrutinib
In force
 · High confidence
Crystal Pharmatech Co., Ltd. and Suzhou Pengxu Pharmatech Co., Ltd.In force
High confidence
US 9,957,240Crystalline Forms of Trisodium Supramolecular Complex Comprising Valsartan and AHU-377 and Methods Thereof
In force
 · High confidence
Crystal Pharmatech Co., Ltd. and Suzhou Pengxu Pharmatech Co., Ltd.In force
High confidence
US 10,508,087Crystalline Forms of Trisodium Supramolecular Complex Comprising Valsartan and AHU-377 and Methods Thereof
In force
 · High confidence
Crystal Pharmatech Co., Ltd. and Suzhou Pengxu Pharmatech Co., Ltd.In force
High confidence
US 10,246,418New Crystal Form of Lenvatinib Methanesulfonate Salt and Preparation Method Thereof
In force
 · High confidence
Crystal Pharmatech Co., Ltd.In force
High confidence
US 10,138,239Preparation Method of Crystalline Form a of PCI-32765
Lapsed Nov 27, 2022 on the fee record
Ended Nov 27, 2022 · High confidence
Crystal Pharmatech Co., Ltd.Lapsed Nov 27, 2022 on the fee recordEnded Nov 27, 2022
High confidence
US 10,196,395Crystalline Form Alpha of IPI-145 and Preparation Method Thereof
Lapsed Feb 5, 2023 on the fee record
Ended Feb 5, 2023 · High confidence
Crystal Pharmatech Co., Ltd.Lapsed Feb 5, 2023 on the fee recordEnded Feb 5, 2023
High confidence
US 10,233,144Crystalline Form of AHU377, Preparation Method and Use Thereof
Lapsed Mar 19, 2023 on the fee record
Ended Mar 19, 2023 · High confidence
Crystal Pharmatech Co., Ltd.Lapsed Mar 19, 2023 on the fee recordEnded Mar 19, 2023
High confidence
US 10,246,437New Crystal Form of Neratinib Maleate and Preparation Method Therefor
Lapsed Apr 2, 2023 on the fee record
Ended Apr 2, 2023 · High confidence
Crystal Pharmatech Co., Ltd.Lapsed Apr 2, 2023 on the fee recordEnded Apr 2, 2023
High confidence
US 10,273,262Crystalline Form a of Obeticholic Acid and Preparation Method Thereof
Lapsed Apr 30, 2023 on the fee record
Ended Apr 30, 2023 · High confidence
Crystal Pharmatech Co., Ltd.Lapsed Apr 30, 2023 on the fee recordEnded Apr 30, 2023
High confidence
US 10,308,641Novel Crystal Form of 3-(6-(1-(2,2-Difluorobenzo[D][1,3]DIOXOLE-5-YL)CYCLOPROPANE FORMAMIDO)-3-Methylpyridine-2-YL)BENZOIC Acid and Preparation Method Thereof
Lapsed Jun 4, 2023 on the fee record
Ended Jun 4, 2023 · High confidence
Crystal Pharmatech Co., Ltd.Lapsed Jun 4, 2023 on the fee recordEnded Jun 4, 2023
High confidence
7 more patents in this group · Pro
10 of 17 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 17, including 12 expired.
Upgrade to Pro
4 of these are in force and held by Crystal Pharmatech Co., Ltd..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited